We showed that MNX1, MNX1-AS1, and MNX1-AS2 expressions are dysregulated in most cancers analysed, with particularly high fold changes observed in uterine, prostate, oesophageal, colorectal, and lung cancers. This evidence concerns the gene MNX1 and cancer.